Diskussionsleiter: K. Lorenz (Dortmund)
(P452) | Nitro oleic acid protects from cardiac hypertrophy, fibrosis and diastolic dysfunction in a murine model of hypertensive heart disease | |
S. Geißen, D. Mehrkens, A.-K. Schätzle, M. Mollenhauer, M. Adam, A. Klinke, S. Baldus, V. Rudolph (Köln) | ||
(P453) | Sex differences in oestrogen-dependent macrophage activation in cardiac chronic inflammation | |
M. L. Barcena de Arellano, M. Niehues, A. Beling, V. Regitz-Zagrosek (Berlin) | ||
(P454) | A novel in vitro cardiomyocyte model using human induced pluripotent stem cells for the investigation of cardiac metabolism in diabetes mellitus | |
M. M. Elsaied, A. González Delgado, A. Kumar, B. Greber, H. Sauer, M. Wartenberg, C. Schulze, M. M. Elsaied, KIMI Jena (Jena, Münster, Gießen) | ||
(P455) | Fibrotic myocardial remodeling is regulated by RKIP and Nrf2. | |
A. Kazakov, A. Trouvain, R. Hall, C. Werner, S. Rodionycheva, F. Lammert, C. Maack, K. Lorenz, M. Böhm, U. Laufs (Homburg/Saar, Dortmund) | ||
(P456) | The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction | |
S. Meyer, A. Jungmann, C. Dieterich, M. Zhang, F. Lasitschka, S. Werkmeister, J. Haas, O. J. Müller, M. Boutros, M. Nahrendorf, S. Hardt, H. A. Katus, F. Leuschner (Heidelberg; Boston, US) | ||
(P457) | Regulation and role of NEU1 sialidase in the heart after ischemia/reperfusion | |
I. Sieve, S. Erschow, I. Dallmann, C.-W. Lee, K. Wohlan, B. Stapel, M. Ricke-Hoch, M. Scherr, D. Hilfiker-Kleiner (Hannover) |